Mauskopf, Josephine; Annemans, Lieven; Hill, Andrew M.; … - In: PharmacoEconomics 28 (2010) S1, pp. 1-16
Darunavir boosted by low-dose ritonavir (DRV/r), at a daily dose of 600/100 mg twice a day (bid), has been shown to be superior to alternative highly active antiretroviral therapy (HAART) regimens for the management of treatment-experienced, HIV-infected adults in the phase IIb POWER trials...